Skip to main content
. 2016 Jun 30;7(31):49289–49298. doi: 10.18632/oncotarget.10334

Figure 2.

Figure 2

Expression of the individual hormone receptors AR, PR and ERα in metastatic lesions based on its expression in primary tumor. 48% of the primary tumors with corresponding metastatic lesions were AR positive (IHC score 1–9) (A). Graphs show distribution of AR expression in the metastatic lesions from AR positive primary tumors (B) and AR negative primary tumors (C). 61% of the primary tumors with corresponding metastatic lesions were PR positive (IHC score 1–9) (D). Graphs show distribution of PR expression in the metastatic lesions from the PR positive primary tumors (E) and PR negative primary tumors (F). 52% of the primary tumors with corresponding metastatic lesions were ER positive (IHC score 4–9) (G). Graphs show distribution of ER expression in the ER positive primary tumors (H) and ER negative primary tumors (I). Expression patterns in individual metastases from AR positive patients (J) and AR negative patients (K) are shown as AR (purple), PR (green) and ERα (orange) in J and K. One line of circles represents one metastasis, and shows the difference in hormone receptor expression in that specific metastasis. Only patients with one or more AR positive metastases are shown. *Only primary tumors with corresponding metastases included.